AST-001

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameAST-001
Drug Alias NameAST-001 注射液AST-001
ClassificationSmall molecules > Small Molecule-Drug Conjugates
Mechanisms of ActionAldo-keto-reductase family 1 member C3 substratesKRAS G12D inhibitors
TargetsAldo-keto-reductase family 1 member C3KRAS G12D
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAscentawits Pharmaceuticals Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAscentawits Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A